Coyol Free Zone: A Leading Hub for Cardiac and Cardiovascular Device Manufacturers
Coyol Free Zone is home to several top manufacturers of cardiac and cardiovascular devices, which positively impact people’s lives through significant innovations in the healthcare technology industry, thus enabling greater access to health and treatments.
They manufacture products that range from cardiology solutions, Image Guided Therapy Devices, and state-of-the-art heart valves to the groundbreaking Intravascular Lithotripsy (IVL) that works with sonic pressure waves, among others.
Some of these companies are:
- Abbott Medical
- Cardinal Health
- Philips
- Theragenics Corporation
Coyol Free Zone as a Medical Device hub in the center of the Americas, is strategic for the establishment of heartcare companies. We provide the ideal conditions for these companies to thrive in their goal of simplifying medical procedures through innovative technology.
The successful operation of these firms also translates into thousands of quality jobs as well as the development of the local Life Sciences industry.
The use of technology in the field of Medical Devices is transforming the way heart diseases are diagnosed and treated, and the work of companies based in Coyol Free Zone are an example of such progress:
Abbott Medical
Based in Coyol Free Zone since 2010, the vascular manufacturing facility in Costa Rica has been producing some of the world’s most advanced technologies to treat people with various vascular diseases.
Abbott produces catheters that are used in minimally invasive procedures to treat coronary and peripheral artery disease. It also manufactures heart valves that are designed to treat severe aortic stenosis in patients at high surgical risk.
The company also manufactures cardiac ablation catheters at its Coyol Free Zone facility. These catheters are used in procedures to guide a tube into the heart to destroy small areas of tissue that may be causing an abnormal heartbeat.
Cardinal Health
Cardinal Health has nearly 1,000 employees in the country and has been operating in the Coyol Free Zone since 2017. The company is involved in the development and manufacture of products such as anti-embolic compression stockings, which aid in preventing vein collapse in patients with morbid obesity or pulmonary embolism.
Anti-embolic stockings help to reduce the incidence of deep vein thrombosis in patients by up to 50% and are important in improving blood circulation in their legs.
In addition, they prevent the damaging effects of venous distention that can occur during surgery and hospitalization of bariatric patients and others. These stockings allow a flow of blood from the legs back to the heart with graduated pressure.
The company also produces umbilical vessel catheters and peripherally inserted central catheters in its facility at Coyol Free Zone, and it is currently developing improvements in sequential compression devices through new generation pumps and devices that further optimize performance.
Philips
Philips has a complete portfolio of cardiology solutions in equipment, software, applications and services. At its plant located in Coyol Free Zone, it develops catheters designed to diagnose vascular diseases caused by blockages in the arteries.
In addition, it manufactures guide wires, which are crucial devices for measuring blood pressure before and after a blockage in the coronary arteries. These can detect signs of deterioration in cardiac tissue and facilitate decision-making about the best treatment for the patient.
These devices are used in public and private hospitals in the country.
The company’s multimodal plant in Coyol Free Zone, which commenced operations in 2020, currently employs over 2,700 individuals.
Theragenics Corporation
Theragenics has been operating in the Coyol Free Zone since 2014, manufacturing and developing vascular access devices for various treatments, including heart procedures. These devices are essential for all procedures that require entry into the circulatory system.
The company is developing two projects involving devices made with new resins that have different levels of radio-opacity. This allows doctors to have an improved view during the use of fluoroscopy for accessing the vascular system.
It will also open a new plant in Coyol Free Zone to produce specialized medical needles, guidewires, and other components for minimally invasive medical devices.
The facility, expected to open by 2025, will be equipped with state-of-the-art technology and machinery. It will have the capacity to produce high-precision and often complex components for leading medical device products.